Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin vs Duloxetine in Chemotherapy-induced Peripheral Neuropathy
NCT06711978Completed
- Sponsor
- Pusan National University Hospital
- Start
- Dec 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mirogabalin in chemotherapy-induced peripheral neuropathy (CIPN) (2 arms), sponsored by Pusan National University Hospital. Primary endpoint: Brief Pain Inventory-Short Form at 4 weeks. Started Dec 2024; status: completed.
02
Drugs
mirogabalin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT06711978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06711978.